Jamieson Wellness (JWEL) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
14 Nov, 2025Executive summary
Achieved record revenue of $733.8M in 2024 and 13.2% year-over-year revenue growth in Q3 2025, driven by 16.5% branded growth and strong performance across Canada, U.S., China, and international markets.
Youtheory revenue grew nearly 17% in Q3, with innovation and digital channel expansion supporting momentum.
International expansion, especially in the Middle East and China, contributed to double-digit growth, with China revenue up over 60% in Q3.
Marketing and product innovation campaigns led to high consumer engagement and market share gains.
Appointed Gayle Tait to the Board, bringing digital and CPG expertise to support ongoing digital transformation.
Financial highlights
Q3 2025 consolidated revenue reached $199.3 million, up 13.2% year-over-year; 2024 full-year revenue was $733.8M, with a 5-year CAGR of 16.3%.
Gross profit margin rose by 350 basis points to 41.9%, driven by higher branded sales, especially in China.
Adjusted EBITDA increased to $38 million in Q3 and $141.0M in 2024; 2025 guidance is $158–$162 million.
Adjusted net earnings were $17.7 million in Q3; adjusted diluted EPS was $0.41 in Q3 and $1.61 in 2024, with 2025 guidance of $1.82–$1.88.
SG&A expenses rose 24.7% in Q3, mainly due to variable compensation and increased marketing spend in China.
Outlook and guidance
Fiscal 2025 consolidated revenue expected between $810–$830 million (10.4%–13.1% growth); adjusted EBITDA of $158–$162 million (12%–15% growth); adjusted diluted EPS of $1.82–$1.88 (13%–17% growth).
Q4 2025 guidance: consolidated revenue of $263–$283 million; Jamieson Brands revenue of $218–$238 million; Strategic Partners revenue up to $45 million.
Growth targets by region for 2025: Canada +5–7%, U.S. +8–12%, China +45–50%, International +20–25%.
Strategic Partners segment expected to decline by approximately 5% in 2025.
Guidance reflects higher expectations for China and Youtheory, and lower for Strategic Partners due to planned reductions.
Latest events from Jamieson Wellness
- Branded revenue up 16%, China drives growth; 2026 outlook targets double-digit expansion.JWEL
Q4 202526 Feb 2026 - Q2 revenue up 10.3% to $184.8M, China sales doubled, and dividend raised 11%.JWEL
Q2 20242 Feb 2026 - Q3 revenue up 16.3% to $176.2M, with record China growth and improved margins.JWEL
Q3 202415 Jan 2026 - Targeting $1B+ revenue, global expansion and innovation drive strong growth across key markets.JWEL
Investor Day 202524 Dec 2025 - Double-digit branded growth in 2024 sets up strong 2025 outlook, led by China and global markets.JWEL
Q4 20241 Dec 2025 - Q1 2025 revenue up 14%, China up 52%, margins and guidance strong for the year.JWEL
Q1 202525 Nov 2025 - Q2 revenue up 7.7%, China sales surged 71%, margins and 2025 guidance improved, dividend up 9.5%.JWEL
Q2 202523 Nov 2025